EP2653873
Samsetningar og notkun til meðhöndlunar á heila- og mænusiggi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.2.2008EP published:
20.7.2022EP application number:
13169139.6
EP translation filed:
20.7.2022Grant published:
15.8.2022EPO information:
European Patent Register
Max expiry date:
6.2.2028Expiry date:
6.2.2027Next due date:
28.2.2027
Title in English:
Compositions and uses for treating Multiple SclerosisLanguage of the patent:
English
Timeline
Today
7.2.2008EP application
20.7.2022EP Publication
20.7.2022Translation submitted
15.8.2022Registration published
6.2.2027Expires
Owner
Name:
Biogen MA Inc.Address:
225 Binney Street, Cambridge, MA 02142, US
Inventor
Name:
Lukashev, Matvey, E.Address:
Tewksbury, MA 01876, US
Name:
O'Neill, GilmoreAddress:
Medford, MA 02155, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
888921 PDate:
8.2.2007Country:
US
Supplementary protection
SPC number:
SPC418
Classification
Categories:
G01N 33/68, G01N 33/50
Annual fees
Number
Paid
Expires
Payer
Number: 16
Paid: 27.2.2023
Expires: 6.2.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 23.1.2024
Expires: 6.2.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 24.1.2025
Expires: 6.2.2026
Payer: Árnason Faktor ehf.
Number: 19
Paid: 4.2.2026
Expires: 6.2.2027
Payer: Árnason Faktor ehf.